Featuring new data from 15 fully curated genes, 497 clinical trials and more A new release for COSMIC Actionability is...

It has been 20 years since COSMIC was first launched, yet our journey to fully understanding cancer genes is far...

Explore QIAGEN CLC Genomics Workbench Premium Food and feed safety is a main concern for food authorities, centers of disease...

Your tools can make or break your analysis, so we pitted the top B-cell receptor reconstruction tools against each other....

QIAGEN launches QCI Secondary Analysis, a new cloud-based secondary analysis solution for oncology and inherited disease applications that enables high-throughput...

  More mutations, better annotations, confident classifications HGMD Professional 2024.1 is now available, expanding the world’s largest collection of human...

How expert-curated cancer data from COSMIC and HSMD can help biopharmaceutical researchers identify and validate targets faster and optimize clinical...

What should you expect from your pathway analysis tools? When it comes to data-driven science, your results are only as...

How expert-curated cancer data from COSMIC and HSMD can help biopharmaceutical researchers identify and validate targets faster and optimize clinical...

As the cost of an individual genome becomes more attainable, laboratories in North America and Europe are experimenting with offering...